Inspire2Live
  • Home
  • About us
    • The patient’s voice
      • Origin story of Inspire2live
      • Mission & vision
      • How we work
      • What sets us apart
      • Partners
      • Funding and financial stewardship
      • Organisation
    • Patient Advocacy
      • What is patient advocacy?
      • Meet our patient advocates
      • Patient stories
      • In memoriam
    • Contact
      • Find us on social media
      • Annual Reports
      • For the media
      • Get in contact
  • Our work
    • Our projects
      • DEEP Diagnostics
      • HPV Related Cancer
      • Cancer Registries
      • Discover all our projects
    • Congresses
      • Upcoming congresses
      • Annual congresses
      • Past congresses
    • World Campus
      • About the World Campus
      • World Campus sesssions
  • Our impact
    • Ambassadors
    • Heroes of cancer
    • Achievements
    • Research & development
    • Access and implementation
  • News & media
  • Join Inspire2live
  • Donate
Select Page
Home > News & media > In the media > Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
March 29, 2021

https://journals.lww.com/hemasphere/Fulltext/2020/10000/Personalized_Treatment_for_Hematologic_Diseases_in.8.aspx

More news

Advocacy | Knocking on the door until they listen

December 22nd, 2024

READ MORE

Access to treatment: Medicines that don’t reach the patient don’t cure

December 12th, 2024

READ MORE

Nicole flying higher than ever

December 12th, 2024

READ MORE

Navigation

Home

The patient’s voice

Patient advocacy

World Campus

Our impact

Research & development

More Inspire2Live

Our mission & vision

How we work

Partners

Congresses

News & media

ANBI statement

Join us

Donate

As a company

Become a patient advocate

Become a partner

Contact us

Follow on social media



Facebook



Twitter



LinkedIn



YouTube



Instagram

Disclaimer | Privacy statement | Cookie statement | ANBI number: 8220 32 752
Disclaimer | Privacy statement | Cookie statement | ANBI number: 8220 32 752
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy